IT1249732B - Oligonucleotidi antisenso. - Google Patents

Oligonucleotidi antisenso.

Info

Publication number
IT1249732B
IT1249732B ITRM910890A ITRM910890A IT1249732B IT 1249732 B IT1249732 B IT 1249732B IT RM910890 A ITRM910890 A IT RM910890A IT RM910890 A ITRM910890 A IT RM910890A IT 1249732 B IT1249732 B IT 1249732B
Authority
IT
Italy
Prior art keywords
antisense oligonucleotides
hydrogen
heteroatom
residues
hydrocarbyl
Prior art date
Application number
ITRM910890A
Other languages
English (en)
Inventor
Adolfo Iribarren
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Priority to ITRM910890A priority Critical patent/IT1249732B/it
Publication of ITRM910890A0 publication Critical patent/ITRM910890A0/it
Priority to EP92830639A priority patent/EP0547008A1/en
Priority to JP4353819A priority patent/JPH0687882A/ja
Publication of ITRM910890A1 publication Critical patent/ITRM910890A1/it
Application granted granted Critical
Publication of IT1249732B publication Critical patent/IT1249732B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/312—Phosphonates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
    • C12N2310/3521—Methyl
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
    • C12N2310/3523—Allyl
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/353—Nature of the modification linked to the nucleic acid via an atom other than carbon
    • C12N2310/3531—Hydrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Oligonucleotidi antisenso, caratterizzati dal fatto di essere 2'-desossi-2'-C-idrocarbil-oligonucleotidi con configurazione 2'R oppure 2'S e di avere la seguente formula generale (1) (FORMULA I) in cui n è un numero compreso da 0 a 200;R1 rappresenta residui idrocarbile, quali alchile, alchenile e aralchile, che eventualmente sono sostituiti almeno una volta mediante gruppi funzionali;B rappresenta una base eterociclica a uno o più anelli; e R2 e R3 rappresentano, indipendentemente l'uno dall'altro, un eteroatomo eventualmente legato a idrogeno, idrogeno, oppure hanno il significato dei residui R1, eventualmente legati al fosforo mediante un eteroatomo.
ITRM910890A 1991-11-26 1991-11-26 Oligonucleotidi antisenso. IT1249732B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITRM910890A IT1249732B (it) 1991-11-26 1991-11-26 Oligonucleotidi antisenso.
EP92830639A EP0547008A1 (en) 1991-11-26 1992-11-25 New antisense oligonucleotides
JP4353819A JPH0687882A (ja) 1991-11-26 1992-11-26 新規アンチセンスオリゴヌクレオチド

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910890A IT1249732B (it) 1991-11-26 1991-11-26 Oligonucleotidi antisenso.

Publications (3)

Publication Number Publication Date
ITRM910890A0 ITRM910890A0 (it) 1991-11-26
ITRM910890A1 ITRM910890A1 (it) 1993-05-26
IT1249732B true IT1249732B (it) 1995-03-09

Family

ID=11400470

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM910890A IT1249732B (it) 1991-11-26 1991-11-26 Oligonucleotidi antisenso.

Country Status (3)

Country Link
EP (1) EP0547008A1 (it)
JP (1) JPH0687882A (it)
IT (1) IT1249732B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627053A (en) * 1994-03-29 1997-05-06 Ribozyme Pharmaceuticals, Inc. 2'deoxy-2'-alkylnucleotide containing nucleic acid
WO1998004575A2 (en) * 1996-07-31 1998-02-05 Gilead Sciences, Inc. Lipophilic oligonucleotide analogs
DE19962567C1 (de) * 1999-12-23 2000-12-14 Wacker Chemie Gmbh Verfahren zur Herstellung von 1.3-Dihalogen-1.1.3.3-tetra(organyl)disiloxanen
HRP20110193T1 (hr) 2006-10-10 2011-05-31 Medivir Ab Inhibitor hcv nukleozida
EA025341B1 (ru) 2010-09-22 2016-12-30 Алиос Биофарма, Инк. Замещенные аналоги нуклеотидов
SG10201610936RA (en) 2011-12-22 2017-02-27 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
US8980865B2 (en) 2011-12-22 2015-03-17 Alios Biopharma, Inc. Substituted nucleotide analogs
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US8916538B2 (en) 2012-03-21 2014-12-23 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
HK1203356A1 (en) 2012-03-22 2015-10-30 艾丽奥斯生物制药有限公司 Pharmaceutical combinations comprising a thionucleotide analog
GEAP202215528A (en) 2015-03-06 2022-11-10 Atea Pharmaceuticals Inc B-D-2'-DEOXY-2'a-FLUORO-2'-B-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
BR112019004297A2 (pt) 2016-09-07 2019-05-28 Atea Pharmaceuticals Inc método, uso de uma quantidade eficaz de um composto, composto, e, composição farmacêutica.
SG11201906163TA (en) 2017-02-01 2019-08-27 Atea Pharmaceuticals Inc Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
EP3773753A4 (en) 2018-04-10 2021-12-22 ATEA Pharmaceuticals, Inc. TREATMENT OF PATIENTS INFECTED WITH THE HEPATITIS C VIRUS WITH CIRRHOSIS
US10874687B1 (en) 2020-02-27 2020-12-29 Atea Pharmaceuticals, Inc. Highly active compounds against COVID-19
JP2024525164A (ja) 2021-06-17 2024-07-10 アテア ファーマシューティカルズ， インコーポレイテッド 有利な抗ｈｃｖ併用療法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449769A (en) * 1989-03-06 1995-09-12 Gen-Probe Incorporated Method and reagent for sulfurization of organophosphorous compounds
DE3916871A1 (de) * 1989-05-24 1990-11-29 Boehringer Mannheim Gmbh Modifiziertes phosphoramidit-verfahren zur herstellung von modifizierten nukleinsaeuren

Also Published As

Publication number Publication date
ITRM910890A1 (it) 1993-05-26
EP0547008A1 (en) 1993-06-16
JPH0687882A (ja) 1994-03-29
ITRM910890A0 (it) 1991-11-26

Similar Documents

Publication Publication Date Title
IT1249732B (it) Oligonucleotidi antisenso.
DE69821600D1 (de) Von hydroxysäuren abgeleitete monomere und daraus hergestellte polymere
DE69530001D1 (de) Verbesserungen von oder in bezug auf endometrialfunktion
ES8104200A1 (es) Un procedimiento para preparar mercaptoacildipeptidos
MY108259A (en) Liquid detergent composition
ES2143004T3 (es) Derivados de la milbemicina, su preparacion y uso.
ATE276274T1 (de) Konjugate von alpha-msh mit einer fettsäure, verfahren zu ihrer herstellung und ihre verwendung als medikament
ES2059595T3 (es) Beta-carbonil-carboxiamidas de 1,3-tiazolidinas.
IT1221246B (it) Alimentatore con tensione di uscita sviluppata gradualmente all' atto dell' accensione
ES2057065T3 (es) Composicion mejoradora de la dismnesia.
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
AR002003A1 (es) Oligorribonucleotidos de sentido inverso con estructuras unidas por grupos amida, compuestos intermediarios, composicion farmaceutica que los contiene,un proceso para la elaboracion de dicha composicion farmaceutica y el grupo de dichos compuestos como medicamentos.
DE68928767D1 (de) Imido-percarbonsäuren
DE3672446D1 (en) Pantothenolderivate.
ES469578A1 (es) Procedimiento para la preparacion de colorantes de condensa-cion con 5-alquil -0 5-alquenil-sulfofenil-halogenpirimidi- nas
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne
AU6306886A (en) Alkylcarboxamides of pyridylalkylamines, their preparation and their use in human and veterinary medicine
ES480329A1 (es) Procedimiento para la preparacion de derivados de acidos benzoilfenoxialcanoicos.
ES8704897A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas
IL96501A (en) 14 alpha, 17 alpha-bridged estratrienes, processes for the preparation thereof, and pharmaceutical compositions containing them
ES8506011A1 (es) Procedimiento para la obtencion de un derivado de tetrahidrobenzotiazol
FI883316A7 (fi) 3-asyylioksibisyklo/3.3.0/oktan-7-oni-2-karboksyylihappoesterirasemaattien hajotus stereospesifisellä, entsymaattisella tai mikrobiologisella asylaatin hydrolyysillä
NO944937D0 (no) Asymmetrisk hydrogenering av furoimidazolderivater
ATE65986T1 (de) Propanolabkoemmlinge.
SE7606355L (sv) Hypolipedemiskt medel

Legal Events

Date Code Title Description
0001 Granted